(NORD) BEVERLY HILLS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in supporting Nordic and U.S. life sciences companies in establishing themselves in the U.S. market, announces it has applied to uplist its common stock (the “Common Stock”) to the Nasdaq Capital Market (“Nasdaq”). The Common Stock will continue to trade on the OTCQB Market until the uplisting is approved.
Related Questions
What is the timeline and likelihood of the Nasdaq Capital Market uplisting being approved, and what potential catalysts could accelerate or delay it?
How will the uplisting affect the company's liquidity, bid-ask spread, and overall market valuation compared to its current OTCQB trading?
What are the implications of the uplist for the company's growth strategy, financing options, and competitive positioning within the life sciences consulting sector?